Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Enliven Therapeutics (ELVN) Return on Assets (2020 - 2026)

Enliven Therapeutics has reported Return on Assets over the past 7 years, most recently at 0.0% for Q1 2026.

  • Quarterly results put Return on Assets at 0.0% for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was 0.0% (changed 0.0% YoY), and the annual figure for FY2025 was 0.0%, changed 0.0%.
  • Return on Assets reached 0.0% in Q1 2026 per ELVN's latest filing, up from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.01% in Q3 2022.
  • Median Return on Assets over the past 5 years was 0.0% (2024), compared with a mean of 0.0%.
  • Peak annual rise in Return on Assets hit 0bps in 2022, while the deepest fall reached 0bps in 2022.
  • Over 5 years, Return on Assets stood at 0.01% in 2022, then surged by 50bps to 0.0% in 2023, then decreased by -9bps to 0.0% in 2024, then surged by 96bps to 0.0% in 2025, then skyrocketed by 84bps to 0.0% in 2026.
  • Business Quant data shows Return on Assets for ELVN at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.